Cargando…

POS-134 NEW ONSET NEPHROTIC SYNDROME FOLLOWING INACTIVATED SARS-CoV-2 VACCINE

Detalles Bibliográficos
Autores principales:	Lim, Y.S., Leong, C.M., Nge, C.S., Mohamad, H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8854927/ http://dx.doi.org/10.1016/j.ekir.2022.01.146

Ejemplares similares

POS-912 EFFECTIVENESS OF SARS-COV 2 VACCINATION IN KIDNEY TRANSPLANT PATIENTS IN CHILE
por: Pefaur Penna, J., et al.
Publicado: (2022)

Adult-onset nephrotic syndrome following coronavirus disease vaccination
por: Biradar, Vivek, et al.
Publicado: (2021)

POS-973 MEASURING SERORESPONSE TO SARS-CoV-2 INFECTION AND VACCINATIONS IN HAEMODIALYSIS PATIENTS
por: Warrens, H., et al.
Publicado: (2022)

POS-907 COVID-19 AND SARS-CoV-2 VACCINE IN HEMODIALYSIS PATIENTS. EXPERIENCE IN A GUATEMALAN CENTER
por: MAZARIEGOS, C., et al.
Publicado: (2022)

POS-887 GROSS HEMATURIA AFTER SARS-CoV-2 VACCINATION: QUESTIONNAIRE SURVEY IN JAPAN
por: AOKI, R., et al.
Publicado: (2022)

POS-685 SARS-COV2 INFECTION IN PATIENTS ON PERITONEAL DIALYSIS
por: Bettaieb, A., et al.
Publicado: (2022)

New-onset pediatric nephrotic syndrome following Pfizer-BioNTech SARS-CoV-2 vaccination: a case report and literature review
por: Nakazawa, Eriko, et al.
Publicado: (2021)

Inactivated vaccine for SARS-CoV-2
por: Risson, Emma
Publicado: (2020)

Onset of nephrotic syndrome concomitant to SARS-CoV-2 infection in a 3-year-old child
por: Morreale, Alessia, et al.
Publicado: (2021)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine
por: Wilder-Smith, Annelies, et al.
Publicado: (2021)

Nephrotic syndrome and acute kidney injury following CoronaVac anti-SARS-CoV-2 vaccine
por: Unver, Suat, et al.
Publicado: (2021)

POS-085 SEVER SYMPTOMATIC HYPONATREMIA IN SETTING OF MILD SARS-COV2 INFECTION
por: BASHIR, N., et al.
Publicado: (2022)

SARS-CoV-2 infection in children with nephrotic syndrome
por: Krishnasamy, Sudarsan, et al.
Publicado: (2022)

Development of an inactivated vaccine candidate for SARS-CoV-2
por: Gao, Qiang, et al.
Publicado: (2020)

Development of an Inactivated Vaccine against SARS CoV-2
por: Pavel, Shaikh Terkis Islam, et al.
Publicado: (2021)

Inactivated SARS-CoV-2 vaccine for people with HIV
por: Wolday, Dawit, et al.
Publicado: (2022)

Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
por: Jara, Alejandro, et al.
Publicado: (2021)

Sars-cov-2-vaccine-inactivated: Encephalopathy: case report
Publicado: (2022)

POS-868 THE USE OF OXIRIS MEMBRANE IN CRITICAL ILL PATIENTS WITH SARS COV-2 PNEUMONIA
por: Rizo Topete MD, L., et al.
Publicado: (2022)

POS-940 ANTIBODY RESPONSE TO PFIZER BNT162b2 VACCINE IN HEMODIALYSIS PATIENTS: THE PREVIOUS SARS-CoV-2 INFECTION INFLUENCE
por: FREITAS, M., et al.
Publicado: (2022)

New-onset and relapse of nephrotic syndrome following COVID-19 vaccination: a questionnaire survey in Japan
por: Nakagawa, Naoki, et al.
Publicado: (2022)

New-onset Nephrotic Syndrome after Janssen COVID-19 Vaccination: a Case Report and Literature Review
por: Lim, Jeong-Hoon, et al.
Publicado: (2021)

POS-954 COVID-19 IN PATIENTS ON PERITONEAL DIALYSIS
por: MOHD DIN, M.R., et al.
Publicado: (2022)

Predictors of Relapse in Adult-Onset Nephrotic Minimal Change Disease
por: Lee, Hajeong, et al.
Publicado: (2016)

POS-861 INCIDENCE AND RISK FACTORS OF ACUTE KIDNEY INJURY WITH SARS-CoV-2 INFECTION IN DISADVANTAGED POPULATION
por: NAVA-VARGAS, M.G., et al.
Publicado: (2022)

Vitamin D deficiency and inactivated SARS-CoV-2 vaccines
por: Wu, Chia-Chao, et al.
Publicado: (2021)

VITT with inactivated SARS-CoV-2 vaccine – index case
por: Devi, Kanta, et al.
Publicado: (2022)

An overview on inactivated and live‐attenuated SARS‐CoV‐2 vaccines
por: Khoshnood, Saeed, et al.
Publicado: (2022)

POS-092 CYTOMEGALOVIRUS AND SARS-COV-2 COINFECTION IN KIDNEY TRANSPLANT RECIPIENT: A CASE REPORT
por: Ben Salem, M., et al.
Publicado: (2021)

Distinct immune signatures discriminate between asymptomatic and presymptomatic SARS-CoV-2(pos) subjects
por: Yu, Shanhe, et al.
Publicado: (2021)

POS-970 PREVALENCE OF SARS-CoV-2 INFECTION IN HAEMODIALYSIS PATIENTS- A RETROSPECTIVE STUDY
por: VORA, A., et al.
Publicado: (2022)

Cases of severe acute liver injury following inactivated SARS-CoV-2 vaccination.
por: Kulkarni, Anand V., et al.
Publicado: (2022)

Early onset nephrotic syndrome with dysmorphic facies and microcephaly
por: Mubarak, Muhammed, et al.
Publicado: (2015)

Long-term Outcomes of Childhood Onset Nephrotic Syndrome
por: Hjorten, Rebecca, et al.
Publicado: (2016)

Worsening Hypothyroidism in the Setting of New-Onset Nephrotic Syndrome
por: Wang, Qi, et al.
Publicado: (2023)

Immunogenicity and safety of SARS-CoV-2 mRNA vaccine in patients with nephrotic syndrome receiving immunosuppressive agents
por: Kamei, Koichi, et al.
Publicado: (2022)

A promising inactivated whole-virion SARS-CoV-2 vaccine
por: Isakova-Sivak, Irina, et al.
Publicado: (2021)

Preparation, characterization and preliminary in vivo studies of inactivated SARS-CoV vaccine
por: Tang, Lin, et al.
Publicado: (2003)

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies
por: Kandeil, Ahmed, et al.
Publicado: (2021)

Immunological evaluation of an inactivated SARS-CoV-2 vaccine in rhesus macaques
por: Chen, Hongbo, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_pr07d985c3o2cqqrm0jvbke6v4